In order to test the hypothesis (Munn, Zhou, Attwood, Bondarev, Conway, Marshall, Brown, Mellor, Science 281 (1998) 1191^1193) that localized placental tryptophan catabolism prevents immune rejection of the mammalian fetus, the cellular localization and characteristics of human placental indoleamine 2,3-dioxygenase (EC 1.13.11.42) were studied. The localization of indoleamine 2,3-dioxygenase activity was determined quantitatively using cell fractionation by differential and discontinuous sucrose gradient centrifugation. Enzyme activity was looked for in isolated brush border microvillous plasma membranes of placental syncytiotrophoblast. We found that this membrane preparation (which showed a 32.4-fold purification from the starting homogenate with reference to the activity of a membrane marker enzyme, alkaline phosphatase (EC 3.1.3.1)) was strongly negatively enriched with indoleamine 2,3-dioxygenase (which showed a one twenty-fifth decrease in its specific activity). Placental indoleamine 2,3-dioxygenase is thus not expressed in the maternal facing brush border membrane of syncytiotrophoblast. 1-Methyl-DL-tryptophan which was used by Munn et al. as a key experimental tool for inhibiting indoleamine 2,3-dioxygenase in the murine model showed a competitive inhibition of human placental indoleamine 2,3-dioxygenase with L-tryptophan. The hypothesis, based on experiments performed in mouse, may therefore be applicable to avoidance of immune rejection of the fetus in human pregnancy. ß
Introduction
Indoleamine 2,3-dioxygenase is a heme-containing protein that catalyzes the oxidative cleavage of the pyrrole ring of the indole nucleus of various indoleamines upon the insertion of two oxygen atoms of molecular oxygen [1] . Previous studies have shown that indoleamine 2,3-dioxygenase activity is relatively highly expressed in the lung, small intestine and placenta of mammals such as rabbits [2] , rats [3] , mice [4] and humans [5] . Although the precise physiological role of indoleamine 2,3-dioxygenase is still unknown, the enzyme is induced under pathological conditions including virus infection [6] , parasitic infestation [7] and tumor transplantation into allogenic animals [8, 9] . Interferon-Q, which exerts potent immunomodulatory and antiproliferative e¡ects, strongly induces the expression of genes coding for indoleamine 2,3-dioxygenase [10] . Therefore the antiproliferative e¡ect of interferon-Q on tumor cells and the inhibitory e¡ect on intracellular pathogens are at least partly attributable to the depletion of the essential amino acid, L-tryptophan, through the induction of indoleamine 2,3-dioxygenase. With regard to its role in normal pregnancy, Munn et al. [11] have recently proposed the hypothesis that the expression of this enzyme in the placenta is crucial to prevention of immunological rejection of the fetal allograft. They administered 1-methyl-tryptophan, a pharmacologic inhibitor of intestinal indoleamine 2,3-dioxygenase [12] , to pregnant mice and found a rapid T cell-induced rejection of allogenic concepti. They suggested that the mechanism of T cell inhibition involves indoleamine 2,3-dioxygenase-dependent localized depletion of L-tryptophan at the site of placentation. We therefore investigated a key feature of the human placental enzyme in an attempt to extend the ¢ndings of Munn et al. [11] to human pregnancy. In the human, is placental indoleamine 2,3-dioxygenase a cytoplasmic or a cell surface enzyme? This has not been studied previously.
We have also addressed the question of whether in the human as in the mouse, the enzyme is inhibited by 1-methyl-tryptophan.
Materials and methods

Materials
L-Tryptophan, 1-methyl-DL-tryptophan, L-kynurenine, norharman, indo-3-acetamide, L-indolylacetonitrile, 3-L-indoleacrylic acid, p-dimethylaminobenzaldehyde and bovine liver catalase were purchased from Sigma (Poole, Dorset, UK). All other chemicals were of the highest purity commercially available.
Preparation of indoleamine 2,3-dioxygenase from placenta
For normal measurement of placental indoleamine 2,3-dioxygenase activity the enzyme was prepared from term placenta as follows. The fetal membrane was removed, the placenta was cut into cotyledons and the decidual surface was removed. The villous tissue was washed and homogenized in 3 vols. of icecold 250 mM sucrose containing 50 mM Tris-HEPES bu¡er (pH 7.5) and 0.2 mM EDTA. Homogenization was performed ¢rstly using a Waring blender operated for 3 min and secondly using a PotterElvehjem homogenizer for ten strokes. The suspension was ¢ltered through three layers of cotton gauze. The ¢ltrate was then centrifuged for 30 min at 10 000Ug. The supernatant was collected and stored 320³C until used.
Assay of indoleamine 2,3-dioxygenase
Indoleamine 2,3-dioxygenase activity was determined colorimetrically by a modi¢ed procedure of the method of Takikawa et al. [13] . The reaction was initiated by adding 0.5 ml of the enzyme suspension (approx. 2 mg of protein) to 0.5 ml of the incubation medium composed of 0.8 mM L-tryptophan, 40 mM ascorbic acid, 20 WM methylene blue, 200 units/ml catalase and 100 mM potassium phosphate bu¡er (pH 6.5). Other additions are described in the legend to Fig. 2 . Both the enzyme suspension and the incubation medium were preincubated independently at 37³C for 5 min before mixing, followed by further incubation at 37³C for 30 min. The reaction was terminated by adding 0.2 ml of 30% (w/v) trichloroacetic acid, and further incubated at 50³C for 30 min to hydrolyze N-formylkynurenine produced by indoleamine 2,3-dioxygenase to kynurenine. The reaction mixture was then centrifuged for 20 min at 3000Ug to remove sediment. 0.8 ml of the supernatant was collected and then 0.8 ml of 1% (w/v) p-dimethylaminobenzaldehyde in acetic acid was added. The absorbance at 480 nm for the yellow color derived from kynurenine was determined.
Subcellular fractionation of indoleamine 2,3-dioxygenase
Subcellular fractionation of human placental indoleamine was performed from freshly obtained normal term placenta according to the standard method for preparing brush border membrane of syncytiotrophoblasts [14] .
Analytical measurements
Alkaline phosphatase activity was determined by a previously established procedure [15] . Protein concentration was determined by the method of Lowry et al. [16] using bovine serum albumin as a standard.
Results and discussion
In order to investigate the cellular localization of indoleamine 2,3-dioxygenase, we carried out subcellular fractionation to determine whether the placental isoform of this enzyme is membrane bound or cytoplasmic. The isolation procedure of apical (brush border) membrane of placental syncytiotrophoblasts (facing towards the maternal circulation) is schematically illustrated in Fig. 1 . By applying the crude brush border membrane fraction (Ppt 2) to a discontinuous sucrose gradient centrifugation further puri¢cation of the membrane fraction (Int 2) was obtained (cf. Kelley et al. [17] ). That this puri¢ed membrane preparation contains multiple transport systems for various amino acids expressed at the maternal face of the syncytiotrophoblast has been con¢rmed [14, 18] . Table 1 summarizes the activities of indoleamine 2,3-dioxygenase and alkaline phosphatase (a marker enzyme of the brush border membrane) at each stage of the isolation procedure shown in Fig. 1 . The crude (Ppt 2) and puri¢ed (Int 2) membrane preparation showed a degree of alkaline phosphatase enrichment 13.5 and 32.4 times greater than that of the villous tissue homogenate. While indoleamine 2,3-dioxygenase showed an enrichment in cytoplasmic fraction (Sup 3) and one sixth and one twenty-¢fth decrease in its speci¢c activity in Ppt 2 and Int 2. These results indicate that the placental isoform of indoleamine 2,3-dioxygenase is not expressed at the brush border membrane of the syncytiotrophoblast but is a cytoplasmic enzyme and that L-tryptophan therefore has to enter the cell in order to be catabolized by this enzyme. It is possible to speculate that transmembrane transport may reg- Activities were determined as described in the text. Values are mean þ S.D. for speci¢c activity and mean for yield and puri¢cation. Samples correspond to stages as shown in Fig. 1 . Sup, supernatant; Ppt, pellet; Int, interface.
ulate the extent of L-tryptophan catabolism and hence the mechanism responsible for the suppression of the maternal immune response to allogenic conceptus [11] . We then characterized placental indoleamine 2,3-dioxygenase. As previously reported by Yamazaki et al. [5] , the enzyme required a reducing system, ascorbic acid and methylene blue, for the catalytic activity. The maximal activity of indoleamine 2,3-dioxygenase was observed at 10 mM ascorbic acid and 5 WM methylene blue (data not shown). Catalase at a concentration of 100 units/ml was also required for maximal enzyme activity to escape the inhibitory e¡ect of hydrogen peroxide produced by the reducing system (i.e. ascorbic acid and methylene blue) as a result of reduction of oxygen [19] . The placental isoform of indoleamine 2,3-dioxygenase oxidizes L-tryptophan preferentially with a pH optimum of 6.5. However, the enzyme had a broad substrate speci¢c-ity and was able to react with D-tryptophan, 5-hydroxy-L-tryptophan, tryptamine and 5-hydroxytryptamine. The rate of N-formylkynurenine formation as a function of L-tryptophan concentration showed saturable hyperbolic curves that obeyed MichaelisMenten kinetics (data not shown). The calculated values of the Michaelis constant, K m , and maximum velocity, V max , for L-tryptophan were 24.6 WM and 0.51 nmol/min per mg of protein, respectively.
1-Methyl-DL-tryptophan which was used by Munn et al. [11] as a key experimental tool for inhibiting indoleamine 2,3-dioxygenase activity in the pregnant mouse has been reported to be a competitive inhibitor for the rabbit intestinal isoform of the enzyme; no report has yet appeared concerning its e¡ect on human placental indoleamine 2,3-dioxygenase. We therefore investigated the e¡ect of 1-methyl-DL-tryptophan on human placental indoleamine 2,3-dioxygenase and also the e¡ect of norharman and indole derivatives (indo-3-acetamide, L-indolylacetonitrile, 3-L-indoleacrylic acid) which potently inhibit intestinal indoleamine 2,3-dioxygenase and hepatic tryptophan 2,3-dioxygenase (EC 1.13.11.11), respectively [19] . Among these compounds at the concentration of 2 mM, 1-methyl-DL-tryptophan (70%) and norharman (98%) showed marked inhibition of human placental indoleamine 2,3-dioxygenase activity, while indole derivatives tested had no inhibitory e¡ect. None of these compounds were found to serve as substrates for placental indoleamine 2,3-dioxygenase (data not shown). Kinetic studies were then performed using either 1-methyl-DL-tryptophan ( Fig.  2A) or norharman (Fig. 2B) . The apparent values These results showed that 1-methyl-DL-tryptophan was competitive and norharman was uncompetitive with L-tryptophan for human placental indoleamine 2,3-dioxygenase. The K i values giving half-maximal inhibition for L-tryptophan determined by replotting for the apparent K m values against the inhibitor concentrations were found to be 68 WM for 1-methyl-DL-tryptophan and 176 WM for norharman. The pattern of inhibition by norharman with L-tryptophan has been reported to be uncompetitive for rabbit intestinal indoleamine 2,3-dioxygenase and competitive for mouse hepatic tryptophan 2,3-dioxygenase [20] . (Sono and Cady [21] reported, however, noncompetitive inhibition of indoleamine 2,3-dioxygenase by norharman.) The abortifacient action of some L-carboline derivatives in rats has been reported [22] ; this e¡ect we suggest may be attributed to the inhibition of indoleamine 2,3-dioxygenase by L-carboline derivatives. Interestingly, norharman has been found to be a normal constituent of human blood albeit at very low concentrations [23] .
Since the assumption that 1-methyl-DL-tryptophan possesses an inhibitory e¡ect on human placental indoleamine 2,3-dioxygenase has now been con¢rmed, Munn et al.'s hypothesis may therefore be applicable to human pregnancy. In order to clarify more precisely the physiological signi¢cance of placental indoleamine 2,3-dioxygenase, we aim to investigate: (1) transport of L-tryptophan and its underlying regulatory mechanism in the placental syncytiotrophoblast (since indoleamine 2,3-dioxygenase is cytoplasmic, L-tryptophan must enter the syncytiotrophoblast in order for the enzyme to have its e¡ect); (2) regulation of placental indoleamine 2,3-dioxygenase expression by cytokines as observed previously in various other types of cell; (3) comparison of the levels of indoleamine 2,3-dioxygenase expression between normal and abnormal pregnancy such as recurrent miscarriage and preeclampsia.
